Location History:
- Bari, IT (2011)
- Bari BA, IT (2024)
Company Filing History:
1 out of 2 
1 out of 17 
1 out of 1 Years Active: 2011-2024
Title: Paola Vitale: Innovator in Pharmaceutical Chemistry
Introduction
Paola Vitale is a distinguished inventor based in Bari, Italy, known for her contributions to pharmaceutical chemistry. With a focus on developing innovative compounds, she has made significant strides in the field of selective COX-1 inhibitors. Her work has implications for treating various disorders, including cancer and neuroinflammation.
Latest Patents
Paola Vitale holds 2 patents, showcasing her innovative approach to pharmaceutical development. Her latest patents include "Mofezolac derivatives as multi-functions selective COX-1 inhibitors," which relates to a new class of compounds targeting COX-1. This invention not only aims to treat conditions associated with COX-1 but also serves as a tool for investigating the enzyme's structure and function in various diseases, including neurological disorders and gynecological tumors. Another notable patent is "Functionalized diarylisoxazoles inhibitors of cyclooxygenase," which focuses on isoxazole derivatives that inhibit cyclooxygenase-1 (COX-1). These compounds are designed for chemoprevention and treatment of inflammatory syndromes and carcinomas, particularly in the intestinal, ovarian, and cutaneous areas.
Career Highlights
Throughout her career, Paola has worked with notable organizations, including Itel Telecomunicazioni S.r.l. and the University of Bari. Her research has significantly contributed to the understanding and treatment of various medical conditions, establishing her as a key figure in her field.
Collaborations
Paola has collaborated with esteemed colleagues such as Antonio Scilimati and Maria Grazia Perrone, enhancing her research and expanding the impact of her inventions.
Conclusion
Paola Vitale's innovative work in pharmaceutical chemistry, particularly in the development of COX-1 inhibitors, highlights her significant contributions to medical science. Her patents reflect a commitment to addressing critical health issues through research and innovation.